Cerbios-Pharma makes debut at 10th Anniversary HPAPI Summit

news-releasesCERBIOS-PHARMA SA
June 15th 2021

Lugano, Switzerland: – Pharmaceutical ingredient specialist CDMO Cerbios-Pharma SA (Cerbios) will make its debut appearance at the 10th Anniversary HPAPI Summit, held as an online event for 2021.

Cerbios will have its own dedicated virtual Demo Area for the event, to be staffed by Chief Commercial Officer Denis Angioletti and Pharma Senior Consultant Charlie Johnson, who will also use the Hanson Wade event’s proprietary networking platform to reach out to existing and potential partners.

cGMP HPAPI development 

The Demo Booth team and content will highlight Cerbios-Pharma’s almost 30 years’ experience in the cGMP handling of contract development and manufacturing of HPAPIs from early stage development, through clinical trials to commercial supply, seeking to add ‘Value through Innovation’ at every step.

In practice, this means designing efficient synthetic routes, applying Design of Experiment (DoE) and Quality by Design(QbD) approaches to development of New Chemical Entity (NCE) and advanced intermediates, providing a comprehensive CMC service to support all aspects of the development, registration and commercial manufacturing of target molecules.

New HPAPI facility

The event team will also be able to provide preliminary details of Cerbios-Pharma’s new large scale HPAPI facility, due to come on stream to coincide with the HPAPI /Summit.

They will also represent the activities of the PROVEO alliance in end-to-end ADC development manufacturing, now managed as a business division of Cerbios-Pharma.

About Cerbios-Pharma

Cerbios is a privately held company located in Lugano, Switzerland, that specializes in the development and manufacturing of both chemical and biological APIs for its partners world-wide.

Exclusive CDMO services are offered for the development and manufacturing of high potency active ingredients (HPAIs) as well as for biological products including monoclonal antibodies, recombinant proteins and antibody drug conjugates (ADCs).

Cerbios provides full CMC support, including the supply of cGMP clinical batches, registration/validation materials and commercially manufactured APIs, with paramount ability to support a successful registration. Cerbios is a worldwide presence with partners in Europe, USA and Japan.

Cerbios Division, PROVEO™, in partnership with AGC Biologics and Oncotec, focuses on integrated ADC manufacturing solutions.

PROVEO can offer an end-to-end ADC service from drug substance development to sterile Fill & Finish.

Learn more at: https://cerbios.swiss

About HPAPI Summit

First staged in 2011, the HPAPI Summit is dedicated to knowledge sharing and best practice in the challenges of safe handling High Potency Active Pharmaceutical Ingredients (HPAPIs), covering the latest containment, industrial hygiene, EHS (Environmental Health & Safety) challenges and outsourcing developments.

The 10th Anniversary HPAPI Summit will be a three-day online event, opening June 22 and live streamed between 1000 and 1700hrs EST (UT+2) each day.

Across two conference streams and four workshops, the 2021 summit will cover such themes as safe handling in R&D and scale up to clinical production, Green Chemistry & lifecycle management, high containment facility design, and continuous manufacturing, automation and emerging technologies.

The event is organised by Hanson Wade with further details at: http://hpapi-summit.com


Click on PROVEO complete supply solution for ADCs for more information on PROVEO.
Click on Cerbios-Pharma Services for detailed information.


CERBIOS-PHARMA Company Brochure

Cerbios-Pharma makes debut at 10th Anniversary HPAPI Summit
Cerbios-Pharma makes debut at 10th Anniversary HPAPI Summit
Cerbios-Pharma makes debut at 10th Anniversary HPAPI Summit

Cerbios-Pharma combines advanced technologies and processes for the safe cGMP handling of  cytotoxic HPAPI payloads